Cumulative Covid-19 vaccine doses administered in country tops 380 million

The cumulative number of COVID-19 vaccine doses administered in the country has surpassed 38 crore, the Union Health Ministry said on Monday.

coronavirus, Covid-19, vaccine
Press Trust of India New Delhi
1 min read Last Updated : Jul 12 2021 | 9:25 PM IST

The cumulative number of COVID-19 vaccine doses administered in the country has surpassed 38 crore, the Union Health Ministry said on Monday.

More than 37.03 lakh doses were administered on Monday, as per a provisional report till 7 pm.

The ministry said 16,61,804 first doses and 1,40,806 second doses were given to beneficiaries in the age group of 18-44 on Monday.

Cumulatively, 11,41,34,915 people in the age group of 18-44 have received their first dose and 38,88,828 have received their second dose of the COVID-19 vaccine since the start of phase-3 of the vaccination drive in the country.

Eight states -- Uttar Pradesh, Madhya Pradesh, Rajasthan, Tamil Nadu, Bihar, Gujarat, Karnataka and Maharashtra -- have administered more than 50 lakh first doses of COVID-19 vaccines in the age group of 18-44 years, the ministry said.

Andhra Pradesh, Assam, Chhattisgarh, Delhi, Haryana, Jharkhand, Kerala, Telangana, Himachal Pradesh, Odisha, Punjab, Uttarakhand and West Bengal have vaccinated more than 10 lakh beneficiaries in the age group of 18-44 with the first dose of COVID-19 vaccine, it added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Jul 12 2021 | 9:25 PM IST

Next Story